Abstract
BackgroundPapillary thyroid cancer (PTC) patients with ipsilateral neck metastatic lymph node (LN) and those with contralateral neck metastatic LN belong to N1b. Only a few studies have reported on comparisons with regard to laterality of metastatic lateral LN. The aim of this study was to evaluate predictive factors for contralateral neck LN metastasis and to determine prognostic factors for recurrence in PTC patients with N1b.MethodsThis retrospective study reviewed the medical records of 390 PTC patients who underwent total thyroidectomy and central LN dissection plus ipsilateral or bilateral modified radical neck dissection (MRND) between January 2004 and December 2012.ResultsDuring a median follow-up of 81 (range, 6–156) months, 84 patients had a recurrence in any lesion. Male gender, a main tumor of more than 2 cm, number of metastatic central LN, number of harvested and metastatic lateral LN, total LN ratio, multifocality, bilaterality, and gross ETE had significance in the patients who underwent bilateral MRND. In multivariate analysis according to recurrence, patients with LN ratio > 0.44 in the central compartment (hazard ratio [HR], 1.890; 95% confidence interval [CI], 1.124–3.178; p = 0.015), LN ratio > 0.29 in the lateral compartment (HR, 2.351; 95% CI, 1.477–3.743; p < 0.001), and multifocality (HR, 1.583; 95% CI, 1.030–2.431; p = 0.036) were associated with worse RFS. However, the type of MRND was statistically significant only in univariate analysis.ConclusionsRecurrence in N1b PTC patients is predicted by central neck LN ratio > 0.44, lateral neck LN ratio > 0.29, and multifocality of tumors. We suggest that patients with these factors should receive short-term follow-up using image modalities like ultrasonography and computed tomography.
Highlights
Papillary thyroid cancer (PTC) patients with ipsilateral neck metastatic lymph node (LN) and those with contralateral neck metastatic lymph nodes (LNs) belong to N1b
Ito et al revealed that N1b PTC patients, regardless of type of modified radical neck dissection (MRND), with metastatic lateral LNs smaller than 3 cm, with less than five metastatic lateral LNs, or without extranodal extension had similar survival outcomes compared with those N1a PTC patients [10]
A considerable number of patients had a recurrence within 5 years in this study; we suggest that patients who had undergone MRND should be checked via neck US every 6 months at least for 5 years
Summary
Papillary thyroid cancer (PTC) patients with ipsilateral neck metastatic lymph node (LN) and those with contralateral neck metastatic LN belong to N1b. The prognosis for PTC is better than for other types of thyroid cancer; the involvement of lymph nodes (LNs) is up to 80% at diagnosis [1]. Ohshima et al reported that patients who underwent thyroidectomy and bilateral MRND had better 10-year survival rate (97.1% vs 83.7%) and lower cancer death (5.8% vs 28.1%) than those who underwent thyroidectomy and ipsilateral MRND [9]. Ito et al revealed that N1b PTC patients, regardless of type of MRND, with metastatic lateral LNs smaller than 3 cm, with less than five metastatic lateral LNs, or without extranodal extension had similar survival outcomes compared with those N1a PTC patients [10]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
